Literature DB >> 13693272

Studies of two kinds of virus particles which comprise influenza A2 virus strains. II. Reactivity with virus inhibitors in normal sera.

P W CHOPPIN, I TAMM.   

Abstract

Inhibitors present in normal human and animal sera prevented hemagglutination by and neutralized infectivity of inhibitor-sensitive influenza A2 virus. Starch zone electrophoresis of sera indicated that the same serum components possess both hemagglutination-inhibiting and neutralizing activities. The greatest amount of inhibitory activity was found in normal horse serum, and the inhibitory activity increased with heating or treatment with concentrated solutions of urea. The inhibitory activities on human, ferret, and rabbit sera were markedly reduced but not completely eliminated by V. cholerae filtrate and purified neuraminidase. The inhibitory activity of horse serum was only moderately reduced by these agents. The nature of the horse serum inhibitor and the differences in the interactions of inhibitor-sensitive and insensitive influenza A2 virus particles and pre-1957 influenza viruses with receptors have been discussed.

Entities:  

Keywords:  INFLUENZA VIRUSES

Mesh:

Year:  1960        PMID: 13693272      PMCID: PMC2137295          DOI: 10.1084/jem.112.5.921

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Studies on Francis inhibitor of influenza virus haemagglutination in rabbit serum fractions obtained by electrophoresis on starch-grain.

Authors:  A HARBOE; R REENAAS; M OPPEDAL
Journal:  Acta Pathol Microbiol Scand       Date:  1958

2.  Purification of neuraminidase from Vibrio cholerae.

Authors:  G SCHRAMM; E MOHR
Journal:  Nature       Date:  1959-06-13       Impact factor: 49.962

3.  Antigenicity of the inhibitor of influenza virus strain A/Asia/57.

Authors:  V M ZHDANOV; V P HAMBURG; G J SVETMOLDAVSKY
Journal:  J Immunol       Date:  1959-01       Impact factor: 5.422

4.  Serologic comparisons with lines of influenza virus isolated and serially transferred in different experimental hosts.

Authors:  K E JENSEN; E MINUSE; T FRANCIS
Journal:  J Immunol       Date:  1957-05       Impact factor: 5.422

5.  New set of type A influenza viruses.

Authors:  K E JENSEN
Journal:  J Am Med Assoc       Date:  1957-08-31

6.  Influenza, 1957: a variant and the pandemic.

Authors:  K E JENSEN; F L DUNN; R Q ROBINSON
Journal:  Prog Med Virol       Date:  1958

7.  Immunological characteristics of N.Y. strains of influenza A virus from the 1957 pandemic.

Authors:  P W CHOPPIN; S OSTERHOUT; I TAMM
Journal:  Proc Soc Exp Biol Med       Date:  1958-07

8.  Zone electrophoresis.

Authors:  H G KUNKEL
Journal:  Methods Biochem Anal       Date:  1954

9.  Influenza; a study of four virus strains isolated in 1951.

Authors:  W SMITH; J C N WESTWOOD; G BELYAVIN
Journal:  Lancet       Date:  1951-12-29       Impact factor: 79.321

10.  Electrophoresis of proteins on filter paper.

Authors:  H G KUNKEL; A TISELIUS
Journal:  J Gen Physiol       Date:  1951-09       Impact factor: 4.086

View more
  15 in total

1.  Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies.

Authors:  J W Yewdell; A J Caton; W Gerhard
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

Review 2.  The influenza pandemic of 2009: lessons and implications.

Authors:  Paul Shapshak; Francesco Chiappelli; Charurut Somboonwit; John Sinnott
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

3.  [In vitro characteristics of largely genetically homogenous influenza virus A2 strains].

Authors:  H J Gerth
Journal:  Arch Gesamte Virusforsch       Date:  1970

4.  Studies on the role of myxovirus neuraminidase in virus-cell receptors interaction by means of direct determination of sialic acid split from cells. I. Experiments on influenza virus-RBC cell system.

Authors:  I V Tsvetkova; M A Lipkind
Journal:  Arch Gesamte Virusforsch       Date:  1968

5.  Analysis of horse serum inhibitors of A2 influenza virus haemagglutination.

Authors:  A Cohen; F Biddle; S E Newland
Journal:  Br J Exp Pathol       Date:  1965-10

6.  [Use of influenza A 2 antigens of various antibody sensitivity and of their ether preparations for the initiation of antibody cadastres].

Authors:  H J Gerth; I Stifter
Journal:  Z Hyg Infektionskr       Date:  1964

7.  Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses.

Authors:  Jens C Krause; Tshidi Tsibane; Terrence M Tumpey; Chelsey J Huffman; Randy Albrecht; David L Blum; Irene Ramos; Ana Fernandez-Sesma; Kathryn M Edwards; Adolfo García-Sastre; Christopher F Basler; James E Crowe
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

8.  Antigenic characterization of influenza A virus matrix protein with monoclonal antibodies.

Authors:  K L van Wyke; J W Yewdell; L J Reck; B R Murphy
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

9.  Attenuation of human influenza A viruses.

Authors:  A S Beare; M L Bynoe
Journal:  Br Med J       Date:  1969-10-25

10.  Influenza pandemics of the 20th century.

Authors:  Edwin D Kilbourne
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.